ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
61 hedge funds and large institutions have $25.8M invested in Zynerba Pharmaceuticals, Inc in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
59% less call options, than puts
Call options by funds: $742K | Put options by funds: $1.8M
Holders
61
Holding in Top 10
–
Calls
$742K
Puts
$1.8M
Top Buyers
| 1 | +$903K | |
| 2 | +$317K | |
| 3 | +$316K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$214K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$190K |
Top Sellers
| 1 | -$4.52M | |
| 2 | -$2.54M | |
| 3 | -$2.13M | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.11M |
| 5 |
Morgan Stanley
New York
|
-$1.62M |